MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on November 10, 2005; DOI: 10.1124/mol.105.014241


0026-895X/06/6902-629-639$20.00
Mol Pharmacol 69:629-639, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.014241v1
69/2/629    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leslie, E. M.
Right arrow Articles by Waalkes, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leslie, E. M.
Right arrow Articles by Waalkes, M. P.

Acquired Cadmium Resistance in Metallothionein-I/II(–/–) Knockout Cells: Role of the T-Type Calcium Channel Cacn{alpha}1G in Cadmium Uptake

Elaine M. Leslie1, Jie Liu, Curtis D. Klaassen, and Michael P. Waalkes

Inorganic Carcinogenesis Section, Laboratory of Comparative Carcinogenesis, National Cancer Institute and National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina (E.M.L., J.L., M.P.W.); and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas (C.D.K.)

Metallothioneins (MTs) are cytoplasmic proteins that sequester certain divalent cations and are considered a primary cellular defense against the toxic transition metal cadmium (Cd2+). MT-I/II(–/–) knockout [MT(–/–)] cells are available and serve as an excellent tool to study non–MT-related mechanisms in metal tolerance. In the current study, Cd2+-resistant MT(–/–) (CdR) and CdR revertant (CdR-rev) cell lines were developed and characterized to investigate non–MT-mediated cellular protection mechanisms. Resistance to Cd2+ was approximately 70-fold higher in CdR than the parental MT(–/–) cell line (IC50 = 20 versus 0.3 µM, respectively) and was stable in the absence of Cd2+ for 35 days. Accumulation of Cd2+ by the CdR cell line was reduced by approximately 95% compared with parental cells, primarily because of a decreased Cd2+ uptake. Cd2+ uptake by the MT(–/–) parental cell line was independent of sodium, energy, and electrogenic potential. Uptake was saturable (Km = 65 nM; Vmax = 4.9 pmol/mg/min) and pH-dependent (maximal at pH 6.5–7). Potent inhibitors of Cd2+ uptake included Zn2+ (IC50 = 7 µM), Mn2+ (IC50 = 0.4 µM), and the T-type Ca2+ channel antagonist mibefradil (IC50 = 5 µM), whereas other metals (including Fe2+) and L-type Ca2+ channel antagonists had little effect. Immunoblot and real-time reverse transcription-polymerase chain reaction analysis indicated that the Cacn{alpha}1G T-type Ca2+ channel was expressed at a reduced level in CdR compared with the parental MT(–/–) cell line, suggesting it is important for Cd2+ uptake. The CdR1-rev cell line was found to have a Cd2+ uptake and sensitivity level in between that of the CdR1 and MT(–/–) cell lines. Consistent with this was an intermediate expression of Cacn{alpha}1G in the CdR-rev cell line. These data suggest that decreased expression of Cacn{alpha}1G protects cells from Cd2+ exposure by limiting Cd2+ uptake.


Received for publication May 22, 2005.

Accepted for publication November 10, 2005.

Address correspondence to: Dr. Michael P. Waalkes, Inorganic Carcinogenesis Section, National Cancer Institute, National Institute of Environmental Health Sciences, P.O. Box 12233, Mail Drop F0-09, 111 Alexander Dr., Research Triangle Park, NC 27709. E-mail: waalkes{at}niehs.nih.gov




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. J. Adle and J. Lee
Expressional Control of a Cadmium-transporting P1B-type ATPase by a Metal Sensing Degradation Signal
J. Biol. Chem., November 14, 2008; 283(46): 31460 - 31468.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
I. Aiba, A. Hossain, and M. T. Kuo
Elevated GSH Level Increases Cadmium Resistance through Down-Regulation of Sp1-Dependent Expression of the Cadmium Transporter ZIP8
Mol. Pharmacol., September 1, 2008; 74(3): 823 - 833.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics